Three influenza pandemics occurred in the 20th century: 1918, 1957, and 1968. These are known as the Spanish, Asian, and Hong Kong influenza, respectively, and represent influenza A virus subtypes H1N1, H2N2, and H3N2. Other outbreaks, such as the 1947 pseudopandemic, 1977 epidemic, and 1976 swine influenza outbreak, were not true pandemics. Pandemics are characterized by major changes in hemagglutinin antigens, often resulting from genetic reassortment with animal influenza viruses. The 1918 pandemic was unique due to its high mortality rate, though the exact cause remains unclear. It is believed that the virus spread from humans to pigs, where it remained relatively unchanged until isolated over a decade later. The 1957 Asian influenza pandemic was the first to be studied in detail, showing a new influenza A virus with distinct antigens. The 1968 Hong Kong influenza pandemic was also significant, with a virus that differed from its predecessor but retained the same neuraminidase antigen. It was less severe than 1918 and 1957, but still caused widespread illness. Pandemics do not follow a predictable pattern and differ from each other. The 1947 pseudopandemic was mild, while the 1977 epidemic was restricted to young people and was caused by the re-emergence of an H1N1 virus. The 1976 swine influenza outbreak was feared to be a potential pandemic but did not result in a full-scale outbreak. Vaccination is the key to preventing influenza, but the effectiveness of vaccines depends on the antigenic match with the circulating virus. The 1957 and 1968 pandemics showed that vaccines based on previous strains were less effective. Preparing for future pandemics involves developing vaccines based on all known influenza subtypes, as the next pandemic could arise from any of these. The 21st century has seen no major influenza pandemics, but the threat remains. Preparing for unpredictable pandemics requires ongoing research and the development of vaccines based on genetic reassortment. The challenge is to create vaccines that can respond to any new influenza strain, as the next pandemic could be caused by any of the 16 known HA subtypes.Three influenza pandemics occurred in the 20th century: 1918, 1957, and 1968. These are known as the Spanish, Asian, and Hong Kong influenza, respectively, and represent influenza A virus subtypes H1N1, H2N2, and H3N2. Other outbreaks, such as the 1947 pseudopandemic, 1977 epidemic, and 1976 swine influenza outbreak, were not true pandemics. Pandemics are characterized by major changes in hemagglutinin antigens, often resulting from genetic reassortment with animal influenza viruses. The 1918 pandemic was unique due to its high mortality rate, though the exact cause remains unclear. It is believed that the virus spread from humans to pigs, where it remained relatively unchanged until isolated over a decade later. The 1957 Asian influenza pandemic was the first to be studied in detail, showing a new influenza A virus with distinct antigens. The 1968 Hong Kong influenza pandemic was also significant, with a virus that differed from its predecessor but retained the same neuraminidase antigen. It was less severe than 1918 and 1957, but still caused widespread illness. Pandemics do not follow a predictable pattern and differ from each other. The 1947 pseudopandemic was mild, while the 1977 epidemic was restricted to young people and was caused by the re-emergence of an H1N1 virus. The 1976 swine influenza outbreak was feared to be a potential pandemic but did not result in a full-scale outbreak. Vaccination is the key to preventing influenza, but the effectiveness of vaccines depends on the antigenic match with the circulating virus. The 1957 and 1968 pandemics showed that vaccines based on previous strains were less effective. Preparing for future pandemics involves developing vaccines based on all known influenza subtypes, as the next pandemic could arise from any of these. The 21st century has seen no major influenza pandemics, but the threat remains. Preparing for unpredictable pandemics requires ongoing research and the development of vaccines based on genetic reassortment. The challenge is to create vaccines that can respond to any new influenza strain, as the next pandemic could be caused by any of the 16 known HA subtypes.